Skip to main content

Hemabate Disease Interactions

There are 7 disease interactions with Hemabate (carboprost).

Major

Carboprost (applies to Hemabate) cardiovascular dysfunction

Major Potential Hazard, High plausibility. Applicable conditions: Ischemic Heart Disease, Hypertension, Hypotension, History - Myocardial Infarction

The use of carboprost is contraindicated in patients with uncontrolled or acute cardiovascular dysfunction. Carboprost induces contraction of smooth muscle, including smooth muscle of the vascular system. Therapy with carboprost should be administered cautiously in patients with a history of cardiovascular dysfunction including a history of hypo or hypertension.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Major

Carboprost (applies to Hemabate) hepatic dysfunction

Major Potential Hazard, High plausibility. Applicable conditions: Liver Disease

The use of carboprost is contraindicated in patients with active hepatic disorders. Carboprost is metabolized by the liver. The serum concentration of carboprost may be increased and the half-life prolonged in patients with active hepatic impairment. Therapy with carboprost should be administered cautiously in patients with a history of hepatic dysfunction.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Major

Carboprost (applies to Hemabate) pulmonary dysfunction

Major Potential Hazard, High plausibility. Applicable conditions: Pulmonary Impairment

The use of carboprost may be associated with bronchospasm, decreased pulmonary blood flow, and/or increased pulmonary arterial pressure. Carboprost induces contraction of smooth muscle, including smooth muscle of the respiratory tract. Therapy with carboprost is contraindicated in patients with active pulmonary disease, and should be administered cautiously in patients with a history of asthma or other pulmonary disorders.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Major

Carboprost (applies to Hemabate) renal dysfunction

Major Potential Hazard, High plausibility.

The use of carboprost is contraindicated in patients with uncontrolled or acute renal dysfunction. Carboprost induces contraction of smooth muscle, including smooth muscle of the vascular system. Therapy with carboprost should be administered cautiously in patients with a history of renal dysfunction.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Moderate

Carboprost (applies to Hemabate) anemia

Moderate Potential Hazard, Moderate plausibility.

The manufacturers recommend to use caution when prescribing carboprost therapy in patients with a history of anemia.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Moderate

Carboprost (applies to Hemabate) diabetes

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Diabetes Mellitus

The manufacturers recommend to use caution when prescribing carboprost therapy in patients with history of diabetes.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn
Moderate

Carboprost (applies to Hemabate) epilepsy

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Seizures

The manufacturers recommend to use caution when prescribing carboprost therapy in patients with a history of epilepsy.

References

  1. (2001) "Product Information. Hemabate (carboprost)." Pharmacia and Upjohn

Hemabate drug interactions

There are 6 drug interactions with Hemabate (carboprost).

Hemabate alcohol/food interactions

There is 1 alcohol/food interaction with Hemabate (carboprost).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer